Article ID Journal Published Year Pages File Type
6821974 Schizophrenia Research 2018 9 Pages PDF
Abstract
The analysis in this study showed that PP1M improves functioning, as measured by the four PSP domain scores, in symptomatic subjects with SCA. Functioning was maintained compared with placebo.
Keywords
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Preview
Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in subjects with schizoaffective disorder
Authors
, , , , , ,